288 related articles for article (PubMed ID: 29937157)
1. Response to tocilizumab treatment in Graves' ophthalmopathy by measuring rectus muscle thickness and chemosis using optical coherence tomography.
de-Pablo-Gómez-de-Liaño L; Fernández-Vigo JI; Troyano-Rivas J; Niño-Rueda C; Romo-López Á; Gómez-de-Liaño R
Arch Soc Esp Oftalmol (Engl Ed); 2018 Aug; 93(8):386-391. PubMed ID: 29937157
[TBL] [Abstract][Full Text] [Related]
2. Optical Coherence Tomography Thickness Measurements of the Extraocular Rectus Muscle Tendons in Graves' Ophthalmopathy.
De-Pablo-Gómez-de-Liaño L; Fernández-Vigo JI; Ventura-Abreu N; Troyano-Rivas J; Niño-Rueda C; Romo-López Á; Gómez-de-Liaño R
J Pediatr Ophthalmol Strabismus; 2018 Nov; 55(6):356-362. PubMed ID: 30160297
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Optical Coherence Tomography and Magnetic Resonance Imaging of Rectus Muscle Thickness Measurements in Graves' Ophthalmopathy.
De-Pablo-Gómez-de-Liaño L; Fernández-Vigo JI; Merino-Menéndez S; Duque-Muñoz M; Gómez-de-Liaño R
J Pediatr Ophthalmol Strabismus; 2019 Sep; 56(5):319-326. PubMed ID: 31545866
[TBL] [Abstract][Full Text] [Related]
4. Investigations of ocular changes, extraocular muscle thickness, and eye movements in Graves' ophthalmopathy.
Jankauskiene J; Imbrasiene D
Medicina (Kaunas); 2006; 42(11):900-3. PubMed ID: 17172791
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of extraocular muscles in Graves' ophthalmopathy using T1 mapping.
Zhu H; Zou M; Wu D; Li B; Su Y; Li Y; Hong S; Yang Z
Eur Radiol; 2023 Dec; 33(12):9074-9083. PubMed ID: 37466707
[TBL] [Abstract][Full Text] [Related]
6. Isolated primary amyloidosis of the inferior rectus muscle mimicking Graves' orbitopathy.
Monteiro ML; Gonçalves AC; Bezerra AM
Einstein (Sao Paulo); 2016; 14(4):553-556. PubMed ID: 28076605
[TBL] [Abstract][Full Text] [Related]
7. Enhanced-depth optical coherence tomography for imaging horizontal rectus muscles in Graves' orbitopathy.
Häner NU; Dysli M; Abegg M; Zinkernagel MS
Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1569-73. PubMed ID: 26047533
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.
Pascual-Camps I; Molina-Pallete R; Bort-Martí MA; Todolí J; España-Gregori E
Orbit; 2018 Dec; 37(6):450-453. PubMed ID: 29420104
[TBL] [Abstract][Full Text] [Related]
9. Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy.
Abdel Razek AA; El-Hadidy M; Moawad ME; El-Metwaly N; El-Said AA
Neuroradiol J; 2017 Jun; 30(3):230-234. PubMed ID: 28379055
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of extraocular muscle with high-field magnetic resonance in patients with Graves' ophthalmopathy with upper-lid retraction.
Chen Y; Jin ZY; Zhang ZH; Xu DD; Meng W; Jiang B; Fang HY; Sun ZY; Chen Y; Sun HY; Feng F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):461-7. PubMed ID: 23134821
[TBL] [Abstract][Full Text] [Related]
11. Assessment of extraocular muscle thickness and correlation study using optical coherence tomography.
de-Pablo-Gómez-de-Liaño L; Fernández-Vigo JI; Ventura-Abreu N; Benito-Pascual B; Narváez-Palazón C; Gómez-de-Liaño R
Arch Soc Esp Oftalmol (Engl Ed); 2018 Aug; 93(8):392-397. PubMed ID: 29398235
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of choroidal thickness and retinal vessel density in patients with inactive Graves' orbitopathy.
Fazil K; Ozturk Karabulut G; Alkin Z
Photodiagnosis Photodyn Ther; 2020 Dec; 32():101898. PubMed ID: 32592913
[TBL] [Abstract][Full Text] [Related]
13. Success Treatment of Severe and Active Graves' Orbitopathy with Tocilizumab After Thyroidectomy and Maximum Dose of Intravenous Methylprednisolone.
Pramono LA
Acta Med Indones; 2023 Oct; 55(4):475-477. PubMed ID: 38213047
[TBL] [Abstract][Full Text] [Related]
14. Tocilizumab for the Management of Corticosteroid-Resistant Mild to Severe Graves' Ophthalmopathy, a Report of Three Cases.
Maldiney T; Deschasse C; Bielefeld P
Ocul Immunol Inflamm; 2020; 28(2):281-284. PubMed ID: 30457413
[No Abstract] [Full Text] [Related]
15. Evaluation of the medial rectus muscle and optic nerve using strain and shear wave elastography in Graves' patients.
Özdemir A; Şahan MH; Asal N; İnal M; Güngüneş A
Jpn J Radiol; 2020 Nov; 38(11):1028-1035. PubMed ID: 32638278
[TBL] [Abstract][Full Text] [Related]
16. Rectus muscle resection in Graves' ophthalmopathy.
Yoo SH; Pineles SL; Goldberg RA; Velez FG
J AAPOS; 2013 Feb; 17(1):9-15. PubMed ID: 23352720
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonic measurement of ocular rectus muscle thickness in patients with Graves' ophthalmopathy.
Imbrasienė D; Jankauskienė J; Stanislovaitienė D
Medicina (Kaunas); 2010; 46(7):472-6. PubMed ID: 20966620
[TBL] [Abstract][Full Text] [Related]
18. Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
Wiersinga WM
Lancet Diabetes Endocrinol; 2017 Feb; 5(2):134-142. PubMed ID: 27346786
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of extraocular muscle volume and exophthalmos reduction after radiation therapy to treat Graves' ophthalmopathy: A pilot study.
Kim M; Chang JH; Lee NK
Eur J Ophthalmol; 2021 Mar; 31(2):340-345. PubMed ID: 31496266
[TBL] [Abstract][Full Text] [Related]
20. Real-time ultrasound elastographic evaluation of extraocular muscle involvement in Graves' ophthalmopathy.
Yuksel N; Unal O; Mutlu M; Ergeldi G; Caglayan M
Orbit; 2020 Jun; 39(3):160-164. PubMed ID: 31296093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
